Skip to content
Back to TRXB

TRex Bio, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 17, 2025
Transactions
3
Purchases
3
Sales
0
Purchase value
$3.80M
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Alexandria Venture Investments, LLC10% owner
4
Filed Oct 15, 2026Period of report Oct 13, 20260001722024-26-000004
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 13, 2026
Common Stock178,571$14.00$2.50M1,346,501Direct
Filing footnotes · 1
  1. F1Each share of preferred stock automatically converted into the Issuer's common stock at a ratio of 3.8649 shares of preferred stock to 1 share of common stock upon closing of the Issuer's initial public offering on October 13, 2026, for no additional consideration. The shares had no expiration date.
Open on SEC EDGAR
SV Life Sciences Fund VI (GP), L.P.10% owner
SV Life Sciences Fund VI, L.P.10% owner
Svlsf VI, LLC10% owner
4
Filed Oct 13, 2026Period of report Oct 8, 20260001829126-26-011084
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseOct 8, 2026
Common StockF1F589,783$14.00$1.26M214,869IndirectBy SV Life Sciences Fund VI, L.P.
PurchaseOct 8, 2026
Common StockF2F63,074$14.00$43.04K7,356IndirectBy SV Life Sciences Fund VI Strategic Partners, L.P.
Filing footnotes · 6
  1. F1The shares are held directly by SV Life Sciences Fund VI, L.P. ("SV Fund VI"). SV Life Sciences Fund VI (GP), L.P. (the "GP LP") is the general partner of SV Fund VI, and SVLSF VI, LLC ("SVLSF") is the general partner of GP LP. Investment and voting decisions of SV Fund VI are made by the investment committee of SVLSF. Each of GP LP and SVLSF disclaims beneficial ownership except to the extent of its pecuniary interest, and this report is not an admission of beneficial ownership for any other purpose.
  2. F2The shares are held directly by SV Life Sciences Fund VI Strategic Partners, L.P. ("SV Strategic Partners VI"). GP LP is the general partner of SV Strategic Partners VI, and SVLSF is the general partner of GP LP. Investment and voting decisions of SV Strategic Partners VI are made by the investment committee of SVLSF. Each of GP LP and SVLSF disclaims beneficial ownership except to the extent of its pecuniary interest, and this report is not an admission of beneficial ownership for any other purpose.
  3. F3The shares are held directly by SV Trex Coinvestment, L.P. ("SV Coinvestment"). GP LP is the general partner of SV Coinvestment, and SVLSF is the general partner of GP LP. Investment and voting decisions of SV Coinvestment are made by the investment committee of SVLSF. Each of GP LP and SVLSF disclaims beneficial ownership and this report is not an admission of beneficial ownership for any other purpose.
  4. F4On October 13, 2026, 3.8649 shares of preferred stock automatically converted into one share of common stock upon the closing of the issuer's initial public offering, for no additional consideration. The preferred stock has no expiration date.
  5. F5Represents shares purchased by SV Fund VI in the issuer's initial public offering.
  6. F6Represents shares purchased by SV Strategic Partners VI in the issuer's initial public offering.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.